Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma

16 Apr 2018

Abstract excerpt

// Saurabh Agarwal 1, * , Giorgio Milazzo 2, * , Kimal Rajapakshe 3, * , Ronald Bernardi 1 , Zaowen Chen 1 , Eveline Barberi 1 , Jan Koster 4 , Giovanni Perini 2, ** , Cristian Coarfa 3, ** and Jason M. Shohet 1, ** 1 Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA 2 Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy 3 Dan L...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Neuroblastoma Research and Treatments
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29755654
DOI: 10.18632/oncotarget.24859

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastomaPMID 29755654Read ↗

MYCN in Neuroblastoma: “Old Wine into New Wineskins”Semantic proximity Read ↗

Neuroblastoma and MYCN.Semantic proximity Read ↗

p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic SignificanceSemantic proximity Read ↗

MYCN as an oncogene in pediatric brain tumorsSemantic proximity Read ↗

The p53 regulatory gene <i>MDM2</i> is a direct transcriptional target of MYCN in neuroblastomaSemantic proximity Read ↗

Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastomaSemantic proximity Read ↗

MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4Semantic proximity Read ↗

The N-myc Oncogene: Maximizing its Targets, Regulation, and Therapeutic PotentialSemantic proximity Read ↗

Mdm2 Deficiency Suppresses MYCN-Driven Neuroblastoma Tumorigenesis In VivoSemantic proximity Read ↗

MYCN-mediated transcriptional repression in neuroblastoma: the other side of the coinSemantic proximity Read ↗

Outcome of the p53-mediated DNA damage response in neuroblastoma is determined by morphological subtype and MYCN expression.Semantic proximity Read ↗

Crosstalk between MYCN and MDM2-p53 signal pathways regulates tumor cell growth and apoptosis in neuroblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.